AFFYXELL THERAPEUTICS

AffyXell was established in January 2020 by Avacta and Daewoong as a joint venture to develop novel mesenchymal stem cell (MSC) therapies.

#SimilarOrganizations #Financial #More

AFFYXELL THERAPEUTICS

Industry:
Biotechnology Therapeutics

Founded:
2020-01-01

Address:
Seoul, Seoul-t'ukpyolsi, South Korea

Country:
South Korea

Total Employee:
1+

Status:
Active

Total Funding:
7.3 M USD


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

remix-therapeutics-logo

Remix Therapeutics

Remix Therapeutics is a biotechnology company.

Investors List

avacta-group_image

Avacta Group

Avacta Group investment in Corporate Round - AffyXell Therapeutics

shinhan-venture-investment_image

Shinhan Venture Investment

Shinhan Venture Investment investment in Series A - AffyXell Therapeutics

kolon-investment_image

Kolon Investment

Kolon Investment investment in Series A - AffyXell Therapeutics

samsung-venture-investment-705d_image

Samsung Venture Investment

Samsung Venture Investment investment in Series A - AffyXell Therapeutics

shinhan-investment-corporation_image

Shinhan Investment

Shinhan Investment investment in Series A - AffyXell Therapeutics

stonebridge-ventures_image

Stonebridge Ventures

Stonebridge Ventures investment in Series A - AffyXell Therapeutics

gyeongnam-venture-investment_image

Gyeongnam Venture Investment

Gyeongnam Venture Investment investment in Series A - AffyXell Therapeutics

smilegate-investment_image

Smilegate Investment

Smilegate Investment investment in Series A - AffyXell Therapeutics

More informations about "AffyXell Therapeutics" on Search Engine